pCDNA4/BDD-FVIII Citations (3)

Originally described in: Biochemical and functional characterization of a recombinant monomeric Factor VIII-Fc fusion protein.
Peters RT, Toby G, Lu Q, Liu T, Kulman JD, Low SC, Bitonti AJ, Pierce GF J Thromb Haemost. 2012 Dec 4. doi: 10.1111/jth.12076. PubMed Journal

---

Articles Citing pCDNA4/BDD-FVIII

Articles
Bioengineering hemophilia A-specific microvascular grafts for delivery of full-length factor VIII into the bloodstream. Neumeyer J, Lin RZ, Wang K, Hong X, Hua T, Croteau SE, Neufeld EJ, Melero-Martin JM. Blood Adv. 2019 Dec 23;3(24):4166-4176. doi: 10.1182/bloodadvances.2019000848. PubMed
Generation of a gene edited hemophilia A patient-derived iPSC cell line, YCMi001-B-1, by targeted insertion of coagulation factor FVIII using CRISPR/Cas9. Sung JJ, Park S, Choi SH, Kim J, Cho MS, Kim DW. Stem Cell Res. 2020 Oct;48:101948. doi: 10.1016/j.scr.2020.101948. Epub 2020 Aug 5. PubMed
Long-term correction of hemophilia A via integration of a functionally enhanced FVIII gene into the AAVS1 locus by nickase in patient-derived iPSCs. Kim DH, Choi SH, Sung JJ, Kim S, Yi H, Park S, Park CW, Oh YW, Lee J, Kim DS, Kim JH, Park CY, Kim DW. Exp Mol Med. 2025 Feb;57(1):184-192. doi: 10.1038/s12276-024-01375-z. Epub 2025 Jan 6. PubMed

If you have published an article using this material, please email us at to have your article added to this page.